About Zevra Therapeutics, Inc. 
Zevra Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 37 Schemes (25.69%)
Foreign Institutions
Held by 51 Foreign Institutions (7.94%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
36 Million
(Quarterly Results - Mar 2026)
Net Profit:
36 Million
Pharmaceuticals & Biotechnology
USD 538 Million (Small Cap)
4.00
NA
0.00%
-0.83
89.05%
3.48






